According to Taijun Hana's research, intraoperative measurement of FGF23 levels may help determine whether the tumor has been fully excised, given that FGF23 has a short half-life of approximately 18.5 min (Hana et al., 2017). The gene discussed is FGF23; the disease is neoplasm.